400mcg Sublingual Misoprostol as First Line Treatment

• Status: Completed
• Trial end date: 2012-08-01
• Target enrollment: 0
• Participant gender: Female

Summary

Women presenting with incomplete abortion and eligible for treatment with misoprostol were offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study hypothesises that women can successfully be treated with misoprostol alone as first line treatment.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Gynuity Health Projects
• Treatments: Misoprostol

Criteria

Inclusion Criteria:

• uterine size less than 12 weeks lmp

• open cervical os

• current or past vaginal bleeding

• willing to provide contact information for follow-up

• over 18 or with guardian consent

Exclusion Criteria:

• suspicion of ectopic pregnancy

• intrauterine device in place

• bad general health (infection, anemia, shoc)